Related Experiment Videos

Induction of beta3-integrin gene expression by sustained activation of the Ras-regulated Raf-MEK-extracellular

D Woods1, H Cherwinski, E Venetsanakos

  • 1Cancer Research Institute and Department of Cellular and Molecular Pharmacology, San Francisco, California 94115, USA.

Insights

The Ras-activated Raf-MEK-extracellular signal-regulated kinase (ERK) pathway regulates integrin gene expression, impacting cancer cell invasion. This pathway controls specific integrin subunits, affecting cell adhesion and migration during oncogenic transformation.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Cancer Research

Background:

  • Integrin receptors mediate cell-extracellular matrix interactions crucial for cancer cell invasion and metastasis.
  • Mechanisms regulating integrin gene expression are not fully understood.
  • The Ras-Raf-MEK-ERK signaling pathway is implicated in cellular processes including proliferation and survival.

Purpose of the Study:

  • To investigate the role of the Ras-activated Raf-MEK-extracellular signal-regulated kinase (ERK) signaling pathway in regulating integrin gene expression.
  • To determine how alterations in integrin expression affect cancer cell behavior.

Main Methods:

  • Pharmacological inhibition of MEK1 in human cancer cell lines (melanoma, pancreatic carcinoma).
  • Conditional activation of the Raf-MEK-ERK pathway in NIH 3T3 cells and other cell types (fibroblasts, endothelial cells).
  • Analysis of cell surface integrin expression, mRNA levels, and cell adhesion/spreading assays.

Main Results:

  • Inhibition of MEK1 reduced cell surface expression of alpha6- and beta3-integrin in cancer cells.
  • Activation of the Raf-MEK-ERK pathway induced alpha6- and beta3-integrin expression in NIH 3T3 cells.
  • Raf-induced beta3-integrin expression was mRNA-dependent and required sustained pathway activation, impacting cell adhesion and migration.

Conclusions:

  • The Raf-MEK-ERK pathway specifically controls individual integrin subunit expression.
  • Altered integrin expression induced by oncogenic signaling pathways may contribute to changes in cell adhesion and migration during cancer progression.
  • Targeting this pathway could offer therapeutic strategies for invasive cancers.

Related Concept Videos